Journal of General Internal Medicine

, Volume 25, Issue 9, pp 891–892 | Cite as

N-of-1 Trials: A New Future?



  1. 1.
    Guyatt G, Sackett D, Taylor D. Determining optimal therapy. Randomized trials in individual patients. N Engl J Med. 1986;314(14):889–92.CrossRefPubMedGoogle Scholar
  2. 2.
    Larson EB, Ellsworth AJ, Oas J. Randomized clinical trials in single patients during a 2-year period. JAMA. 1993;270:2708–12.CrossRefPubMedGoogle Scholar
  3. 3.
    Smith-Bindman R, Miglioretti DL, Larson EB. Rising use of diagnostic medical imaging in a large integrated healthcare system. Health Affairs. 2008;27(6):1491–1502. PMCID:PMC2765780.CrossRefPubMedGoogle Scholar
  4. 4.
    Scuffham PA, Nikles J, Mitchell GK et al. Using N-of-1 trials to improve patient management and save costs. J Gen Intern Med 2010; DOI:  10.1007/s11606-010-1352-7.
  5. 5.
    Kravitz R, Duan N, Niedzinski E, Hay M, Subramanian S, Weisner T. What ever happened to N-of-1 trials? Insiders’ perspectives and a look to the future. Milbank Q. 2009;86(4):533–55.CrossRefGoogle Scholar
  6. 6.
    Yelland M, Poulos C, Pillans P et al. N-of-1 randomized trials to assess the efficacy of gabapentin for chronic neuropathic pain. Pain Med. 2009;10(4):754–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Featherstone HJ, Beitman BD, Irby DM. Distorted learning from unusual medical anecdotes. Med Educ. 1984;18:155–8.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2010

Authors and Affiliations

  1. 1.Group Health Research InstituteSeattleUSA

Personalised recommendations